HEMOPHILIA TREATMENT: NEW INSIGHTS CONTRIBUTE TO MINIMIZE OR ELIMINATE SIDE EFFECTS IN THE FUTURE
Immune responses against Factor VIII, which is used to treat hemophilia A (bleeding disorder), are influenced by the microenvironment of antigen presenting cells. This is the result of a scientific study conducted in cooperation between the Institute Krems Bioanalytics of IMC University of Applied Sciences Krems ...
Katharinan Steinitz Christian Lubich Brigitte Hoelbl Markus Weiller Birgitm Reipert Thomas Prenninger
Source: pharmiweb.com